logo
Omega-3 Supplements Combined With Weightlifting May Improve Overall Health

Omega-3 Supplements Combined With Weightlifting May Improve Overall Health

Health Line6 days ago
Omega-3 supplements combined with weightlifting could result in improvements to strength and health.
A new study suggests that incorporating omega-3s into a strength training regimen positively impacts heart and brain health and can lead to fitness gains.
Due to the limited scope of the research, it's unclear whether the findings are applicable to the broader population.
Omega-3 fatty acids play an essential role in numerous bodily functions, including brain and eye health. When consumed in adequate amounts, they've also been linked to improved heart health markers and mental health.
Now, researchers say combining omega-3 supplements with consistent weight training may offer significant health benefits as well.
A study, recently published in Nutrients, found that athletes who supplemented with omega-3 fatty acids during a strength-training regimen experienced improvements in cholesterol profiles, brain-health markers, and, notably, strength gains compared with those who did not.
'The combination of omega-3 supplementation with resistance training resulted in meaningful improvements not only in biochemical markers but also in core components of physical performance such as muscular strength, agility, reaction time, and explosive power,' the study authors wrote.
However, significant limitations remain. The study included only healthy men with a history of strength training, making it unclear if the findings would translate to the general public, particularly those with existing chronic disease.
'Because this excludes the public, it is unclear if there would be such benefits for the entirety of a population,' said Alyssa Kwan, MS, RD, a clinical dietitian in cardiology at Stanford Medicine who wasn't involved in the study.
Nonetheless, the study suggests that omega-3 supplementation may provide a cost-effective, convenient approach to enhancing exercise performance.
Omega-3s improve cholesterol, brain health, and fitness
Researchers in Turkey conducted a randomized trial to assess the effects of omega-3 supplementation with weight training. Two groups of men followed the same weightlifting regimen, but only one group received the supplements.
Thirty men aged 18 to 30 were recruited for the trial. Participants were only included if they met a stringent set of criteria:
a strength-training history of at least three years
absence of chronic medical conditions
non-smokers
non-drinkers of alcohol
ability to train at least three days per week
Participants must not have a history as professional athletes or have used ergogenic aids to enhance performance, such as creatine, omega-3 supplements, protein powders, or branched-chain amino acids (BCAAs), within six months of the trial.
A total of 15 participants were randomized to receive omega-3 supplements, while the remaining participants served as controls. The daily omega-3 dosage was 3,150 mg, selected based on prior studies reporting performance-enhancing effects at similar levels.
Both groups performed strength training three days per week, comprising one upper-body day, one lower-body day and one full-body day. Researchers standardized gym conditions — including lighting, temperature and equipment — to minimize performance variability.
Additionally, to minimize confounding factors, both groups followed a rigorously standardized diet supervised by a certified dietitian.
By the end of the trial, supplemented participants experienced multi-systemic health and performance benefits versus controls. Key health outcomes included:
Performance gains included:
13.6% increase in bench-press one-rep max (1RM)
9.7% increase in squat 1RM
improved power, speed, agility, and reaction time
'The fact that such improvements were observed even in healthy, physically active individuals suggests that omega-3 can be considered a valuable performance-enhancing aid for athletes and those engaged in regular physical activity,' wrote the study authors.
More research is needed to better understand how these supplements will affect a broader population.
Can omega-3 supplements promote overall health?
It's unclear whether the health and performance benefits of omega-3 supplementation and weightlifting would extend to the broader population.
Still, the health benefits observed would be meaningful, even if isolated from the aspects related to exercise performance.
'These benefits could have a large impact on longevity. While exercise is one of the best ways to reduce the risk of cardiometabolic diseases, omega-3s have also been shown to have a beneficial impact as well. Improvements in lipid profiles could reduce the risk of heart attack and stroke as well as cognitive decline,' said Kristin Kirkpatrick, MS, RD, a nutritionist at the Cleveland Clinic, and co-author of ' Regenerative Health,' who wasn't involved in the study.
Meanwhile, Kwan adds, 'We do understand that omega-3s have anti-inflammatory benefits and are very important for immune resilience and a general health benefit.'
Your body doesn't naturally produce omega-3s, which means they must be obtained from omega-3-rich foods like fatty fish, walnuts, or chia seeds. Omega-3 supplements, typically sold as pills or oils, can help fill the gap for those who don't regularly consume sufficient amounts of omega-3-rich foods.
However, experts say food-based sources of omega-3s are generally preferable to seeking out a supplement.
'Health benefits can be linked and achieved by just a healthy diet alone, such as eating fish. This supports an overall healthy diet as well,' said Kwan.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Doctors Say This Is the Best Seat on a Plane to Avoid Getting Sick
Doctors Say This Is the Best Seat on a Plane to Avoid Getting Sick

Yahoo

time41 minutes ago

  • Yahoo

Doctors Say This Is the Best Seat on a Plane to Avoid Getting Sick

There's a reason everyone freaked out about riding on airplanes during the pandemic: it's an easy way to get sick if you don't take precautions. 'Airline carriers are impressive carriers of the common cold,' says Anthony Ognjan, D.O., FACP., a board-certified osteopathic physician specializing in infectious diseases. The good news is you can greatly reduce your risk of getting sick during a flight — and no, you don't need to travel in a bubble. Just follow the tips below from board-certified physicians. What makes it so easy to get sick during a flight? For starters, when you're on a plane, you're stuck in an enclosed space with quite a few people. 'On most commercial airplanes, there are a lot of people in close proximity for an extended period of time,' says Kathleen N. Mueller, M.D., FAAFP, the director of the American Academy of Family Physicians. 'We know that respiratory droplets that come from a cough or sneeze are one of the most common ways to contract an illness like influenza or COVID-19 and with that many people in an enclosed space, you may find yourself exposed more frequently than you would in other situations.' On top of that, airplane environments are like paradise for illness-causing bacteria and viruses. 'The air inside airplane cabins is notoriously dry with humidity levels often dropping below 20%, significantly lower than what your body is used to,' says Ognjan. 'For comparison, most homes maintain humidity levels between 30 and 60%. Low levels of humidity can affect the body's natural defense system, including mucus in the nose and your throat drying up, creating a much more tolerant environment for germs.' Simply put, flights create a perfect storm for spreading germs: lots of people contained in an area with low humidity. Fortunately, there are a few simple steps you can take to offset those risks and avoid getting sick when you're flying. What can you do to prevent contracting an illness on an airplane? Use these doctor-approved tips to stay healthy during air travel. 'Generally speaking, a middle or aisle seat will have more contact with other passengers than a window seat will,' says Dr. Mueller. Of course, picking this seat isn't a guaranteed way to avoid germs, as research shows, it all depends on how close you are to an infected person, but Dr. Ognjan agrees that a window seat — especially one in the back of the plane — is often the safest. 'The last couple rows of the cabin prevent you from being breathed or coughed on from behind,' he says. This is to lower the chances that you'll need to relieve yourself in an airplane bathroom. 'You have no control over what germs existed before you entered, and they are not cleaned mid-flight,' says Dr. Ognjan. 'Infections during flights can be transmitted not only by aerosols that remain airborne and can be inhaled, but also by large droplets that settle on surfaces or by direct contact with secretions, body fluids or contaminated surfaces,' says Dr. Ognjan. What's more, 'germs can survive for hours or days after the passenger who brought them on board has departed.' He suggests using disinfectant wipes (not baby wipes) on tray tables, armrests and seat belt buckles before use. Before you eat on a plane, it's always smart to sanitize your hands first, says Dr. Mueller. Also, if you touch any communal surfaces (like the handle on the overhead bins), apply hand sanitizer and do not touch your eyes, mouth or nose afterward. 'It is one of the most likely culprits for increased risk of getting sick while flying,' says Dr. Ognjan. 'Even though it can be tempting, I recommend passing on the caffeine or alcohol, which can dehydrate you in already-dry air,' says Dr. Mueller. Yes, most airplanes have air filtration systems, but research shows masks are still effective at slowing the spread of airborne illnesses, especially on longer flights. They're particularly helpful if you're immunocompromised, notes Dr. Mueller. 'A mask can help protect you from airborne germs, especially if someone nearby is coughing or sneezing,' adds Dr. Ognjan. 'If you notice someone coughing or sneezing, try to move away or ask for a different seat if available.' The bottom line 'I want people to know that it is possible to travel without getting sick, especially if you take the right precautions!' says Dr. Mueller. 'If you have specific questions or concerns about upcoming travel, reach out to your family physician. We're here to help you navigate potentially stressful situations with confidence.' And if you happen to be the one who's sick while traveling, consider masking up and coughing and/or sneezing into your elbow when you're on the plane to lower the odds that you'll infect someone else. You Might Also Like 67 Best Gifts for Women That'll Make Her Smile The Best Pillows for Every Type of Sleeper

Rapid Review: Endometrial Cancer
Rapid Review: Endometrial Cancer

Medscape

timean hour ago

  • Medscape

Rapid Review: Endometrial Cancer

In endometrial cancer, the majority of cases are diagnosed at an early stage, largely due to the hallmark symptom of postmenopausal bleeding. Despite relatively favorable survival rates when caught early — with a 5-year relative survival rate of approximately 95% for localized disease — disparities remain in detection, treatment access, and mortality. ctDNA testing has shown strong value as a noninvasive and highly sensitive method for detecting recurrence in endometrial cancer. ctDNA detects tumor-specific mutations in the bloodstream and is being actively evaluated to track cancer progression, detect early-stage cancers, and monitor therapeutic responses. ctDNA's role for detecting hormone receptor status and tumor histology has not been established for endometrial cancer, and it appears to not be correlated with myometrial invasion depth. Learn more about the presentation of endometrial cancer. In the past year, evidence has emerged which demonstrates that GLP-1 receptor agonists — medications originally approved for diabetes and obesity — reduce the risk for obesity-related cancers. A major research effort found that these drugs decreased cancer incidence, and further research found GLP-1 receptor agonists to be comparable to bariatric surgery for obesity-related cancer prevention. GLP-1 therapies now offer a less-invasive alternative to bariatric surgery. Research is ongoing to evaluate the use of GLP-1 medications as a potential therapeutic strategy for endometrial cancer. The other classes have not been shown to reduce risk or are not used in endometrial cancer management. Learn more about the differential diagnosis for endometrial cancer. Recent advances in molecular and genomic profiling have significantly refined the precision with which therapies can be selected for patients with endometrial cancer. These tools enable clinicians to pinpoint genetic and molecular characteristics that dictate tumor behavior and response to treatment, improving personalized treatment strategies and overall survival outcomes. Rather than uniformly applying treatments, clinicians have the ability to tailor therapies based on individual molecular profiles. Adjuvant therapy may still be warranted depending on the risk associated with the molecular/genomic subtypes identified, and best practice histopathology evaluation is still needed even when advanced profiling is done. Further research continues to expand the depth and breadth of genomic profiling, making it a crucial element of modern oncology practice. Learn more about the workup for endometrial cancer. The TCGA molecular classification divides endometrial cancers into four biologically distinct subtypes: POLE-ultramutated, MSI-H, copy number-low (endometrioid), and copy number-high (serous-like). These molecular profiles provide prognostic insights and increasingly guide therapeutic strategies beyond traditional histology and staging. For example, POLE-mutated tumors, despite high mutation burdens, have excellent outcomes and may not require aggressive adjuvant therapy. In contrast, copy number-high tumors are associated with poor prognosis and may benefit from more intensive treatment and HER2-targeted therapies. This classification is part of a shift toward personalized medicine in gynecologic oncology. Learn more about guidelines for endometrial cancer. Compared to traditional open surgery, MIS dramatically shortens hospital stays, decreases blood loss, and has fewer overall complications, although it does lengthen operation time. Furthermore, minimally invasive approaches maintain oncologic outcomes comparable to those of traditional open surgery, providing reassurance regarding their safety and efficacy. Because endometrial cancer patients often have obesity, MIS has the potential to reduce the risk for postoperative wound complications. It also is likely to decrease other postoperative morbidities by supporting faster recovery and earlier resumption of normal daily activities. Additionally, lymph node assessment may still be needed after MIS. Learn more about risk assessment in patients with endometrial cancer.

Key Market Players Paving the Way for Advancements in Exosome-Based Diagnostics and Therapeutics
Key Market Players Paving the Way for Advancements in Exosome-Based Diagnostics and Therapeutics

Yahoo

time2 hours ago

  • Yahoo

Key Market Players Paving the Way for Advancements in Exosome-Based Diagnostics and Therapeutics

The global exosome research market is anticipated to expand from USD 214.4 million in 2025 to USD 480.6 million by 2030, at a CAGR of 17.5%. This growth is driven by the rising need for advanced diagnostics due to the prevalence of chronic diseases like cancer and neurodegenerative disorders. Exosomes, serving as biomarkers and therapeutic delivery agents, fulfill this demand. The kits & reagents segment is expected to lead growth, aligning with the increased demand for efficient exosome research tools. North America is projected to experience the highest growth, thanks to significant government investments supporting research initiatives. Key players such as Thermo Fisher Scientific and Bio-Techne are profiled. Exosome Research Market Dublin, July 18, 2025 (GLOBE NEWSWIRE) -- The "Exosome Research Market by Offering (Kits, Reagents (Antibodies, Isolation, Purification), Instruments, Services), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem Cell) - Global Forecast to 2030" report has been added to global exosome research market is projected to reach USD 480.6 million by 2030 from USD 214.4 million in 2025, at a CAGR of 17.5% during the forecast period. The report will help market leaders and new entrants by providing them with the closest approximations of the revenue numbers for the overall exosome research market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges. The expansion of the exosome research market is primarily fueled by the escalating incidence of chronic diseases, including cancer, neurodegenerative disorders, and CVDs; this trend underscores the urgent need for novel diagnostic and therapeutic strategies. Exosomes, due to their properties as potential biomarkers and their capacity to facilitate targeted therapeutic delivery, are uniquely positioned to address the increasing demand for advanced disease diagnostics and treatment modalities. The kits & reagents segment is expected to grow at the highest CAGR during the study academic institutions, biotechnology companies, and diagnostic developers delve deeper into the multifaceted roles of exosomes in disease diagnostics and therapeutic interventions, there has been a notable increase in the demand for standardized, user-friendly kits & reagents. These specialized tools play a crucial role in simplifying and expediting the workflows associated with exosome isolation, purification, labeling, and downstream analysis. Exosomes, nano-sized vesicles secreted by cells, have emerged as significant biomarkers in various diseases, necessitating precise handling and standardization offered by commercially available kits helps ensure that researchers can perform these tasks with consistency and reliability, which is vital in both translational research and preclinical development. In particular, reproducibility is critical in scientific research; utilizing validated kits ensures consistent protocols that minimize variability and enhance overall research outcomes. This reliability is particularly pertinent in biomarker discovery and liquid biopsy research, where the identification of accurate biomarkers is paramount for early disease detection and the growing interest in exosome-based diagnostics - especially within oncology for cancer detection and neurodegenerative diseases like Alzheimer's and Parkinson's - laboratories are increasingly opting for ready-to-use reagent systems. These systems facilitate sample preparation, RNA and DNA extraction, and comprehensive cargo profiling, thereby supporting a range of downstream molecular applications. The integration of such standardized tools not only streamlines the research process but also enhances the quality of data generated, ultimately contributing to the advancement of exosome research in clinical settings. As the landscape of diagnostics continues to evolve, the role of such reliable and efficient kits will become even more pronounced, paving the way for breakthroughs in personalized medicine and targeted America is expected to grow at the highest CAGR in the global exosome research market from 2025 to America maintains its leading position in the global exosome research market, primarily due to substantial government investment and support mechanisms. Key organizations such as the National Institutes of Health (NIH) in the United States are pivotal, channeling significant funding into biomedical research, specifically targeting projects centered on exosomes. This financial endorsement empowers researchers to explore novel applications of exosomes in both diagnostics and therapeutics. For example, in June 2024, the National Heart, Lung, and Blood Institute (NHLBI) renewed a USD 12 million Program Project Grant (PPG) to support researchers at the Lewis Katz School of Medicine at Temple investigation focuses on heart cell-derived exosomes and their involvement in cardiac injury and repair processes. This funding facilitates a deeper understanding of the mechanisms by which exosomes contribute to myocardial tissue regeneration, potentially leading to groundbreaking therapeutic strategies. Likewise, in August 2023, the National Cancer Institute (NCI) allocated USD 2.5 million to the Sylvester Comprehensive Cancer Center to advance research on exosome-based biomarkers for prostate cancer detection through urine and blood assays. Such robust government backing not only propels scientific exploration but also fosters collaboration between academic institutions and industry, thereby cultivating a dynamic research ecosystem. This well-capitalized environment accelerates innovation and reinforces North America's status as a frontrunner in exosome research. As a result, the region continues to draw in investments and talent, driving ongoing growth within the exosome research report provides insights on the following pointers: Analysis of key drivers (increasing investment in pharmaceutical & life sciences research, rising cancer prevalence, and increasing interest in exosome-based procedures), restraints (technical complexity of exosome isolation, and regulatory uncertainty in exosome research), opportunities (rising investments in emerging countries for exosome research, growing interest in exosome-based therapeutics, and increasing demand for personalized medicines), and Challenges (lack of gold standard protocols for exosome development and production and limited understanding of cargo loading). Product Development/Innovation: Detailed insights on upcoming products, research and development activities, and new product approvals/launches in the exosome research market. Market Development: Comprehensive information about lucrative markets; the report analyses the market across varied regions. Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the exosome research market. Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players. A detailed analysis of the key industry players has been done to provide insights into their key strategies, product launches/ approvals, acquisitions, partnerships, agreements, collaborations, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the exosome research market. Key Attributes: Report Attribute Details No. of Pages 325 Forecast Period 2025 - 2030 Estimated Market Value (USD) in 2025 $214.4 Million Forecasted Market Value (USD) by 2030 $480.6 Million Compound Annual Growth Rate 17.5% Regions Covered Global Companies Featured Thermo Fisher Scientific Inc. Qiagen Lonza Danaher Bio-Techne System Biosciences, LLC Amsbio Roosterbio, Inc. Miltenyi Biotec Norgen Biotek Corp. Aethlon Medical, Inc. Creative Medical Technologies Holdings, Inc. Spectris Nanofcm, Inc. Izon Science Limited Capricor Therapeutics, Inc. Anjarium Biosciences AG Ciloa Innovaprep Ilias Biologics Inc. Unchained Labs Rion Inc. Cell Guidance System LLC Inoviq Nx Pharmagen Exopharm Everzom Nanosomix Creative Biolabs For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Exosome Research Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store